Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1
Important safety considerations include the risk of hypoglycemia when tirzepatide is used in combination with insulin or sulfonylureas (requiring dose adjustments of these medications), potential thyroid C-cell tumor risk (contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2), and the possibility of acute pancreatitis
Cell Death Dis 1 , e62 (2010)
You can u003ca href=u0022#can-i-use-my-hsa-for-semaglutide-or-tirzepatideu0022u003euse your HSAu003c/au003e to pay for GLP-1 medication as long as it is prescribed for a legitimate medical condition such as obesity, insulin resistance, type 2 diabetes, or metabolic dysfunction
In some cases, a lower dose or a different weight loss strategy may be safer
US$ 23.74
US$ 29.62
US$ 28.76
US$ 24.29
